Viktor Zarev

Viktor Zarev

InvestorPlace Contributor

Expertise: Science, Technology, Defense, and Medicine Stock Review

Education: BS in Biology from Baylor University, MS in Computer Science from Pace University

Viktor Zarev is a Freelance Writer at InvestorPlace.com, where he aims to elucidate and simplify the world of high-tech stocks and cryptocurrencies. To accomplish this, Viktor specializes in distilling the most pertinent and critical details for investors to focus on.

He also writes in-depth research scripts for defense documentaries on YouTube as well as creative direction and copywriting for game studios. He is also a supply chain specialist in the defense industry.

Viktor holds a BS in Global Health Biology from Baylor University, where he graduated on the Medical Entomology Research Track, studying flaviviruses and developing vector control methods. He is currently earning an MS in Computer Science from Pace University, focusing on artificial intelligence and machine learning.

Recent Articles

3 Defense Stocks to Sell if Trump Wins in November

By Viktor Zarev, InvestorPlace Contributor

Investors should keep an eye out for these three defense stocks to sell before a potential election induced dip.

3 Energy Stocks to Buy in Case of a Red Wave this November

By Viktor Zarev, InvestorPlace Contributor

Investors may want to watch out for a red wave this November as it could change the trajectory of these three energy stocks for the better.

3 Dividend Stocks to Buy in Case Social Security Disappears

By Viktor Zarev, InvestorPlace Contributor

Investors may want to consider which dividend stocks to buy as Social Security starts to dry up for the future generations.

3 Energy Stocks to Sell Ahead of the 2024 Presidential Election

By Viktor Zarev, InvestorPlace Contributor

These are three energy stocks to sell prior to a potential Trump victory in November that would impact the clean energy industry.

3 Healthcare Stocks Injecting AI for Big Gains

By Viktor Zarev, InvestorPlace Contributor

Investors should keep a close eye on these AI healthcare stocks as they revolutionize the future of drug development and patient care.

Load More